ETSEGENET AYELE: Open Payments
NPI 1588752778 · LOS ALAMITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 42 payments from 8 companies in 2025. Trend: 2023 $854 · 2024 $3,008 · 2025 $916
Food & beverage: $512Speaker / faculty: $405
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $433 |
| Lilly USA, LLC | 10 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $141 |
| Novo Nordisk Inc | 7 | $60 |
| Abbott Laboratories | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: CAPLYTA, JARDIANCE, MOUNJARO, Ozempic, FREESTYLE LIBRE 3, Kerendia, GEMTESA, ELIQUIS.
Industry payments across CA — which companies pay providers there.
